Building Clinical-Grade Voice AI: From Copilots to Autonomous Agents with Supreet Deshpande

Join Supreet Deshpande, Co-Founder and CEO of Synthio Labs, in a compelling conversation with Gary Fowler on what it really takes to build and deploy clinical-grade Voice and Agentic AI in highly regulated industries. From moving beyond AI copilots to autonomous agents, to navigating compliance, trust, and ROI in life sciences, this episode goes deep into production-ready AI—not demos.🎯 Insights You’ll Learn:✓ How AI is evolving from copilots to autonomous, agentic systems✓ What “clinical-grade” AI truly means in regulated environments✓ Why context, compliance, and ROI matter more than flashy demos✓ The unique power of Voice AI in pharma, medical, and patient engagement✓ How startups can compete — and win — against large incumbents✓ Lessons from deploying AI at scale inside top global pharma companies✓ The immigrant founder journey and building credibility in enterprise AI🌍 Why This Matters:As AI adoption accelerates, regulated industries like life sciences face a unique challenge: balancing innovation with trust, safety, and compliance. Synthio Labs is redefining how Voice and Agentic AI can be safely deployed across medical, commercial, and patient-facing workflows—unlocking real business outcomes while meeting the highest regulatory standards.👤 Expert Background:• Co-Founder & CEO of Synthio Labs — Voice and Agentic AI for life sciences• Backed by Y Combinator, Peak XV, and Elevation Capital• Works with multiple top-five global pharmaceutical companies• Former leader of Generative AI initiatives for Life Sciences at McKinsey & Company• Background in Machine Learning and Data Science from NC State University• Specialist in building production-grade AI for regulated enterprise environments🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders shaping the future of enterprise and AI-driven industries.💡 Perfect For:AI founders, life sciences executives, pharma leaders, enterprise innovators, Voice AI builders, compliance teams, investors, and anyone interested in deploying AI responsibly at scale.🚀 Timely Topic:As AI systems become more autonomous, the ability to deploy trusted, compliant, and context-aware agents will define the winners in regulated industries—and Synthio is leading that shift.Subscribe for more global founder conversations from GSD Venture Studios:https://gsdvs.com#AgenticAI #VoiceAI #LifeSciencesAI #PharmaInnovation #RegulatedAI #EnterpriseAI #HealthcareAI #StartupLeadership #YCFounders #ImmigrantFounders #AICompliance #GaryFowler #SupreetDeshpande #SynthioLabs #TopGlobalStartups #GSDVentureStudios